Current through Reg. 50, No. 187; September 24, 2024
(1) Violations of the following statutory and
rule provisions are considered to be Minor Administrative Violations:
(a) Section
456.062, F.S., entitled
"Advertisement by Health Care Provider of Free or Discounted Services; Required
Statement."
(b) Section
456.057, F.S., entitled
"Ownership and control of patient records; report or copies of records to be
furnished."
(c) Section
463.011, F.S., entitled
"Exhibition of License."
(d)
Subsection (1), paragraphs (2)(a) and (b) of section
463.012, F.S., entitled
"Prescriptions; Filing; Release; Duplication."
(e) Subsection
463.0135(11),
F.S., entitled "Standards of Practice, " if the violation is of a technical
nature not related to patient care.
(f) Paragraphs (1)(d) and (e) of section
463.014, F.S., entitled "Certain
Acts Prohibited."
(g) For the first
violation of subsection
463.0141, F.S., entitled
"Reports of adverse incidents in the practice of optometry."
(h) Rule
64B13-3.002, F.A.C., entitled
"Responsibility to Patient."
(i)
Rule 64B13-3.005, F.A.C., entitled
"Entrance Sign."
(j) Rule
64B13-3.006, F.A.C., entitled
"Licenses and Signs in Office."
(k)
Rule 64B13-3.012, F.A.C., entitled
"Prescriptions" if the violation consists of failing to release a prescription
or technical omissions or errors on the prescription not related to patient
care.
(l) Section
456.072(1)(nn),
F.S., violating any provision of section
790.338, F.S.
(m) Subsections (1), (2) and (5) of section
465.0276, F.S., entitled
"Dispensing Practitioner, " if the violation is of a technical nature not
related to patient care.
(2) Violations of the following statutory and
rule provisions are considered to be Major Administrative Violations:
(a) Sections
456.072(1)(a), (b), (c), (e), (f), (g), (h), (i),
(k), (m), (q), (r), (s), (w), (x), (cc), (gg), (ii), (jj), (kk), (ll),
(pp), F.S., entitled "Grounds for Discipline;
Penalties; Enforcement."
(b)
Section 463.0135(7) and
(8), F.S., entitled "Standards of
Practice."
(c) Section
463.0135(11),
F.S., entitled "Standards of Practice, " if the violation is substantially
likely to affect patient care.
(d)
Section 463.014(1)(a) and
(b), F.S., entitled "Certain Acts
Prohibited."
(e) For a second or
subsequent violation of Section
463.0141, F.S., entitled
"Reports of adverse incidents in the practice of optometry.
(f) Sections
463.015(1)(a), (b), (c) and (2)(a), (c) and
(d), F.S., entitled "Violations and
Penalties."
(g) Sections
463.016(1)(a), (b), (c), (d), (e), (f), (g), (h),
(i), (k), (l), (m), (n), (o), (q), (r) and
(s), F.S., entitled "Grounds for Disciplinary
Action; Action by the Board."
(h)
Subsection (1), (2) and (5) of Section
465.0276, F.S., entitled
"Dispensing Practitioner, " if the violation is substantially likely to affect
patient care.
(i) Rule
64B13-3.001, F.A.C., entitled
"Confidential Information; Disclosure."
(j) Rule
64B13-3.003, F.A.C., entitled
"Patient Records; Transfer or Death of Licensed Practitioner."
(k) Paragraphs (2)(a), (b), (c), (d), (e),
(f) and subsections (4), (5) and (6) of Rule
64B13-3.009, F.A.C., entitled
"False, Fraudulent, Deceptive and Misleading Advertising Prohibited; Policy;
Definitions; Affirmative Disclosure."
(l) Rule
64B13-3.012, F.A.C., entitled
"Prescriptions" if the violation is substantially likely to affect patient
care.
(m) Subsection (3) of Rule
64B13-11.001, F.A.C., entitled
"Inactive Status."
(n) Rule
64B13-5.001, F.A.C., entitled
"Hours Requirement."
(o) Section
456.0301(1)(a),
F.S., failure by a certified optometrist registered with the United States Drug
Enforcement Administration (DEA) to complete the required two (2) hour course
on prescribing controlled substances prior to January 31, 2019.
(p) Section 465.0276(2)(d)1., F.S.,
dispensing a controlled substance to a person not known to the dispenser
without requiring valid photographic identification or other verification of
identity.
(q) Section
893.055(3),
F.S., failure to report information regarding dispensed controlled substances
to the Prescription Drug Monitoring Program Controlled Substance Dispensing
Information Electronic System.
(r)
Section 893.0551(6),
F.S., failure to maintain confidentiality of information obtained from the
Prescription Drug Monitoring Program Controlled Substance Dispensing
Information Electronic System.
(s)
Section 893.055(8),
F.S., second or subsequent failure to consult the Prescription Drug Monitoring
Program Controlled Substance Dispensing Information Electronic System prior to
prescribing or dispensing a schedule IV or schedule V opioid controlled
substance.
Rulemaking Authority 456.079, 463.005(1) FS. Law
Implemented 456.079, 465.0276(4) FS.
New 2-24-87, Formerly 21Q-15.005, 61F8-15.005, Amended
8-18-96, Formerly 59V-15.005, Amended 5-1-02, 7-6-10, 2-1-12, 7-10-14, 11-5-14,
10-2-18, 12-6-21.